Welcome To the 3rd
SCN8A & SCN2A
Scientific Conference &
Family Gathering

Building a network across Europe and beyond.


The two genes SCN2A and SCN8A both encode for distinct neuronal sodium channels. Mutations of the genes SCN2A or SCN8A are associated with epilepsy, autism spectrum disorder, intellectual disability, movement disorders and sudden unexpected death in epilepsy patients (SUDEP).

As rare sodium-channel disorders they share commonality of research but they require distinct treatment and expertise, due to their divergent roles during brain development. Improved awareness and early diagnosis are crucial for the patients.

The first European SCN2A/SCN8A Conference (Germany, 2021) put the seed for the birth of several SCN2A & SCN8A patient advocacy organisations forming active networks and beginning to share knowledge and educational events.

The second SCN2A and SCN8A conference in Europe took place in 2023 in Køge, Denmark. Professionals from around the world had the opportunity to showcase their knowledge and exchange ideas about current research projects. This gathering not only advanced scientific progress but also fostered the development of new projects aimed at improving the understanding and treatment of SCN2A- and SCN8A-related conditions.
For families of affected individuals, the conference was equally valuable. It provided a space for meaningful exchange and helped strengthen the network within the community. The bonds between families grew closer, creating a stronger sense of unity and offering support in facing the challenges together.

With this positive reflection on the past two years, we are now looking forward to the third SCN2A and SCN8A conference and family gathering, which will take place from May 16, 2025, to May 17, 2025, in Siegburg near Bonn (Germany). Once again, we will have the opportunity to hear fascinating lectures from leading specialists.
In 2025 edition, the focus will be on topics such as disease mechanisms, symptoms beyond epilepsy, treatment, and many other interesting subjects.


3

Third Edition

23

Topics

29

Speakers

Committees


Scientific committee

Elena Gardella, Walid Fazeli


Organizing committee

Stefania Dantone, Anna Homann, Svenja Kaden, Sarah Rieger, Maaike Studemund, Cinzia Scarcelli


Event speakers

Meet our Passionate
event speakers


Elena Gardella

Elena Gardella

MEDICAL DOCTOR

Dept of Clinical Neurophysiology, Danish Epilepsy Centre Filadelfia

Walid Fazeli

Walid Fazeli

MEDICAL DOCTOR

Child Neurologist
Deputy Head of Department
Dept of Pediatric Neurology, University Hospital Bonn, Germany

Rikke S. Møller

Rikke S. Møller

MEDICAL DOCTOR

Head of Department of Epilepsy Genetics, Danish Epilepsy Centre, Filadelfia

Roberto Previtali

Roberto Previtali

MEDICAL DOCTOR

Resident in child neurology and psychiatry, University of Milan, Italy

Dennis Lal

Dennis Lal

UNIVERSITY PROFESSOR

PhD, Associate Professor, Center Director for Neurogenetics, Dept of Neurology
The University of Texas Health Science Center, Houston, USA

Katherine Howell

Katherine Howell

MEDICAL DOCTOR

Royal Children's Hospital, Melbourne, Australia

Sopio Gverdtsiteli

Sopio Gverdtsiteli

MEDICAL DOCTOR

MD, fellow at the Neuroscience Academy Denmark

Francesca Furia

Francesca Furia

MEDICAL DOCTOR

Medical Doctor, Phd Student at University of Southern Denmark

Ingrid Scheffer

Ingrid Scheffer

UNIVERSITY PROFESSOR

AO MBBS PhD FRACP FAA FAES FRS PresAHMS, Melbourne, Australia

Heinz Beck

Heinz Beck

UNIVERSITY PROFESSOR

Experimental epileptology and cognition research, University of Bonn, Germany

Martin Staudt

Martin Staudt

UNIVERSITY PROFESSOR

Professor of Developmental Neuroplasticity, University Tübingen, Germany

Manoj Patel

Manoj Patel

UNIVERSITY PROFESSOR

Professor of Anesthesiology, School of Medicine, University of Virginia, USA

Leah Schust Myers

Leah Schust Myers

PATIENT ADVOCATE

Founder, Executive Director, FamilieSCN2A Foundation, USA

Kacie Craig

Kacie Craig

PATIENT ADVOCATE

MEd, Executive Director at The Cute Syndrome Foundation - USA

SCN2A Germany

SCN2A Germany

PATIENT ADVOCATE

Patient Advocate SCN2A German association

Wenxi Yu

Wenxi Yu

MEDICAL DOCTOR

Ph.D. - Research Investigator, Human Genetics Meisler Lab - University of Michigan - USA

Tobias Brünger

Tobias Brünger

MEDICAL DOCTOR

PhD, Data Scientist, Department of Neurology, The University of Texas Health Science Center at Houston, Houston, USA

Anthony Frosio

Anthony Frosio

MEDICAL DOCTOR

Postdoctoral Researcher presso Policlinico San Donato, Milan, Italy

Daniel Bamborschke

Daniel Bamborschke

MEDICAL DOCTOR

Child Neurologist
Dept of Pediatric Neurology, University Hospital Bonn, Germany

Marina Trivisano

Marina Trivisano

MEDICAL DOCTOR

Neurology, Epilepsy and Movement Disorders Unit - Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy

Sunanjay Bajaj

Sunanjay Bajaj

MEDICAL DOCTOR

MD, Resident Physician, Department of Neurology, The University of Texas Health Science Center, Houston, USA

Angelina Tadic

Angelina Tadic

MEDICAL DOCTOR

PhD student, researcher at SISSA - Trieste, Italy

Anne Koy

Anne Koy

MEDICAL DOCTOR

Head of the Centre for Dystone Childhood Movement Disorders, Koln, Germany

Luismi Aras

Luismi Aras

MEDICAL DOCTOR

Pre-hospital Emergencies Navarra Health Service
SCN8A Spain Advisor
Dravet Syndrome European Federation Scientific Director
ApoyoDravet Scientific Director

Daniel Fritzen

Daniel Fritzen

MEDICAL DOCTOR

Pediatrician
Dept of Pediatric Neurology, University Hospital Bonn, Germany

Praxis Precision Medicines

Praxis Precision Medicines

INDUSTRY

Clinical-stage biopharmaceutical company

Sarah Krämer

Sarah Krämer

Medical Student
(doctoral candidate)

Vanessa Kasto

Vanessa Kasto

Medical Student
(doctoral candidate)

WHY PARTICIPATE

Is This Conference right For You?


Distinctiveness from other epilepsy events

This is the only event in Europe specifically focused on SCN2A and SCN8A, making it unique in its subject matter. This focus is critical, as SCN2A and SCN8A require distinct research approaches and targeted awareness efforts. These efforts are essential to ensure optimal diagnosis and proper treatment for individuals affected by these conditions.

For Families

The aim of the Family Conference is to bring together families and patients with neurodevelopmental disorders associated with mutations in the SCN2A or SCN8A genes, alongside leading experts, clinicians, and researchers in the field. Families will have the opportunity to share their experiences, feelings, hopes, and fears—and to be heard.

For Clinicians and Researchers

The event helps to bring together expertise, evolve data strategies, connect cutting edge research and stimulate future research projects for these devastating disorders.


Event Schedule


Ingrid Scheffer

9:15 AM - 9:35 AM

Precision medicine in DEEs - current status

Ingrid Scheffer

Elena Gardella

9:35 AM - 9:50 AM

SCN8A – clinical spectrum

Elena Gardella

Katherine Howell

9:50 AM - 10:05 AM

SCN2A – clinical spectrum

Katherine Howell

Rikke S. Møller

10:05 AM - 10:25 AM

Genetic mechanisms of sodium-channelopathies

Rikke S. Møller

Heinz Beck

10:25 AM - 10:45 AM

Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy

Heinz Beck

Anne Koy

11:15 AM - 11:35 AM

Movement disorders in childhood and adolescents

Anne Koy

Vanessa Kasto

11:35 AM - 11:40 AM

Movement disorders in SCN2A

Vanessa Kasto, Walid Fazeli

Sunanjay Bajaj

11:40 AM - 11:50 AM

A joined wearable and video analysis data approach to phenotype people with SCN2A and SCN8A

Sunanjay Bajaj, Dennis Lal

Sopio Gverdtsiteli

11:50 AM - 12:00 PM

Episodic ataxia in SCN2A

Sopio Gverdtsiteli, Walid Fazeli

12:00 PM - 12:15 PM

Analysis of over 30,000 phenotypic annotations in individuals with SCN8A-related disorders

1:30 PM - 1:40 PM

SCN2A: anti-seizure medication

Beattie Goad, Daniel Fritzen

Elena Gardella

1:40 PM - 1:50 PM

SCN8A: anti-seizure medication

Elena Gardella

Wenxi Yu

1:50 PM - 2:05 PM

Partial allele-specific knockout by CRISPR rescues SCN8A DEE mice

Wenxi Yu

Manoj Patel

2:05 PM - 2:20 PM

Gene therapy approaches for the treatment of SCN8A DEE

Manoj Patel

Praxis Precision Medicines

2:20 PM - 2:45 PM

Update in drug development for DEEs

Praxis Precision Medicines

Tobias Brünger

4:15 PM - 4:25 PM

Development of clinical and genetic inclusion criteria for high risk disease modifying therapies in SCN2A

Tobias Brünger, Dennis Lal

Anthony Frosio

4:25 PM - 4:35 PM

Functional characterization of SCN8A variants and pharmacological response: Insights for precision medicine

Anthony Frosio

Francesca Furia

4:35 PM - 4:45 PM

Prediction tools reliability in SCN8A-related disorders

Francesca Furia, Roberto Previtali

Francesca Furia

4:45 PM - 4:55 PM

Sleep disturbances in SCN8A

Francesca Furia

Sarah Krämer

4:55 PM - 5:05 PM

Sleep disturbances in SCN2A

Sarah Krämer

Daniel Bamborschke

5:05 PM - 5:15 PM

MRI findings in SCN2A

Daniel Bamborschke

Sopio Gverdtsiteli

5:15 PM - 5:25 PM

NDEEMA across sodium channelopathies

Sopio Gverdtsiteli

Marina Trivisano

5:25 PM - 5:35 PM

Cenobamate in sodium channelopathies

Marina Trivisano

Select a session:

Walid Fazeli

9:05 AM - 9:20 AM

Summary of Day 1: SCN2A

Walid Fazeli

Elena Gardella

9:20 AM - 9:35 AM

Summary of Day 1: SCN8A

Elena Gardella

Kacie Craig

10:00 AM - 10:20 AM

Empowering Caregivers: Perspective on supporting medically complex children

Kacie Craig

Martin Staudt

10:20 AM - 10:45 AM

Pediatric palliative care

Martin Staudt

Angelina Tadic

11:30 AM - 11:50 AM

Detail-oriented visual processing and reduced perception of global patterns in the Scn2a+/- rat model of autism spectrum disorder

Angelina Tadic

11:50 AM - 12:15 PM

Parental mosaicism in DEEs

Elena Gardella

12:15 PM - 12:45 PM

QoL and Burden of illness in SCN2A- and SCN8A- associated disorders

Elena Gardella, Walid Fazeli

SCN2A Germany

2:00 PM - 2:15 PM

How can PAOs grow and strengthen their capacity to support research? Opportunities through philanthropic foundations

SCN2A Germany

Leah Schust Myers

2:15 PM - 2:30 PM

Connections that count: partnering with professionals at every stage of the journey

Leah Schust Myers

Luismi Aras

2:30 PM - 2:45 PM

Building scientific advocacy through collaboration with other DEEs and rare diseases

Luismi Aras

What people said about past Conference


Making This Exciting Conference Possible!

Meet the event sponsors


SCN2A Italy and SCN2A Germany have jointly received support from the Chan Zuckerberg Initiative’s Rare as One program, enabling them to provide financial support for this networking event.

Chan Zuckerberg Initiative

SCN2A Germany has successfully applied for funding from Aktion Mensch.

Aktion Mensch

Platinum Sponsor

Neurocrine Biosciences

Silver Sponsors

Praxis
LongBoard Pharma - Lundbeck
Registration and Venue Info

Join us and build a brighter future for our warriors!


Congress Registration

Registration is free of charge. To register please follow the link 3rd SCN2A & SCN8A conference and family gathering - Registration (or scan the QR code below) and register each participant individually. Registrations are open until May 4th. Later registrations can be accepted depending on the structure’s availabilities.

Registration to the Scientific Conference QR Code

How to reach the Congress Venue

The Kranz Park Hotel is located in Siegburg, near Bonn. The best airports for reaching Siegburg are Frankfurt Main and Cologne Bonn. Siegburg has a well- connected ICE train station, which is only an 8-minute walk from the hotel.
If you are traveling by car, please follow the instructions to reach the following address: Kranz Park Hotel: Mühlenstraße 32–44 - 53721 Siegburg - Deutschland / Germany

Hotel Reservation

All participants and families must book their rooms directly through the Kranz Park Hotel by contacting info@kranzparkhotel.de. Please use the booking code EU Conference for our event.
Single rooms, double rooms, and a limited number of junior suites (suitable as family rooms) are available. If you have any special requirements, please discuss them directly with the hotel.

Update: We offer a 70,00€ support per participant per night to help cover hotel costs. Additionally, we provide non-medical childcare, which must be registered separately at: Leo Kinderevents.